Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.335 USD | -0.37% | +1.89% | -4.61% |
11/06 | IntelGenx Reports Launch of Sale and Investment Solicitation Process | MT |
23/05 | Atai Life Sciences N.V. Announces Board and Supervisory Board Changes | CI |
Business Summary
Number of employees: 83
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Mental Health Innovations
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +34.76% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States and Germany
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +34.76% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Florian Brand
CEO | Chief Executive Officer | 37 | 01/18/01 |
Srinivas Rao
CEO | Chief Executive Officer | 55 | 01/18/01 |
Anne Johnson
DFI | Director of Finance/CFO | 55 | 01/21/01 |
Kevin Craig
CTO | Chief Tech/Sci/R&D Officer | - | 01/21/01 |
Arvind Tewari
COO | Chief Operating Officer | 39 | 01/21/01 |
Frank Stegert
CIO | Chief Investment Officer | 41 | - |
Samantha Bender
CTO | Chief Tech/Sci/R&D Officer | - | 01/21/01 |
Chief Tech/Sci/R&D Officer | 55 | 01/20/01 | |
Chris Lee
CTO | Chief Tech/Sci/R&D Officer | - | 01/21/01 |
Michael Raven
COO | Chief Operating Officer | - | 01/22/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Sabrina Johnson
BRD | Director/Board Member | 57 | 01/21/01 |
Founder | 45 | 01/18/01 | |
Amir Kalali
BRD | Director/Board Member | 58 | 01/23/01 |
Andrea Smiley
BRD | Director/Board Member | 56 | 01/21/01 |
Michael Auerbach
BRD | Director/Board Member | 48 | 01/22/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 167,406,070 | 150,647,814 ( 89.99 %) | 0 | 89.99 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
INTELGENX TECHNOLOGIES CORP. 21.36% | 37,300,000 | 21.36% | 1,492,000 $ |
Company contact information
Group companies
Name | Category and Sector |
---|---|
ATAI Life Sciences AG
ATAI Life Sciences AG Pharmaceuticals: MajorHealth Technology ATAI Life Sciences AG operates as a holding company, which is a global biotech company builder. The company was founded by Christian Angermayer, Lars Christian Wilde, Srinivas G. Rao and Florian Brand in 2018 and is headquartered in Munich, Germany. |
Pharmaceuticals: Major
|
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.61% | 22Cr | |
+35.19% | 5.28TCr | |
-7.46% | 3.89TCr | |
+35.45% | 3.82TCr | |
-10.77% | 2.68TCr | |
+11.82% | 2.62TCr | |
-18.70% | 1.99TCr | |
+35.75% | 1.32TCr | |
+29.36% | 1.22TCr | |
-3.03% | 1.18TCr |
- Stock Market
- Equities
- ATAI Stock
- Company Atai Life Sciences N.V.